Who Buys Repaglinide from India — 112 Importers Behind a $6.9M Market
India's repaglinide import market is served by 112 active buyers who collectively imported $6.9M across 819 shipments. AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) leads with a 7.4% market share, followed by AUROLOGISTICS LLC, (AUROBINDO PHARM and RISING PHARMA HOLDINGS INC. The top 5 buyers together control 34.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Repaglinide Importers — Ranked by Import Value
AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) is the leading repaglinide importer from India, holding a 7.4% share of the $6.9M market across 819 shipments from 112 buyers. The top 5 buyers — AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), RISING PHARMA HOLDINGS INC (UNITED STATES), AUROLOGISTICS LLC(AUROBINDO PHARMA (UNITED STATES), RISING PHARMA HOLDINGS, INC. ,. (UNITED STATES) — collectively control 34.3% of total import value.
Top Repaglinide Buyers & Importers
Ranked by import value · 112 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | AUROLOGISTICS LLC (AUROBINDO PHARMAUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $511.2K | 5 | 7.4% |
| 2 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $483.3K | 5 | 7.0% |
| 3 | RISING PHARMA HOLDINGS INCUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $463.1K | 5 | 6.7% |
| 4 | AUROLOGISTICS LLC(AUROBINDO PHARMAUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $461.1K | 5 | 6.7% |
| 5 | RISING PHARMA HOLDINGS, INC. ,.UNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $452.3K | 5 | 6.5% |
| 6 | AUROLOGISTICS LLC AUROBINDO PHARMUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $443.2K | 5 | 6.4% |
| 7 | AUROLOGISTICS LLCUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $393.2K | 5 | 5.7% |
| 8 | RISING PHARMA HOLDINGS, INC.UNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $368.6K | 5 | 5.3% |
| 9 | ARROW GENERIQUES,FRANCE REPAGLINIDE TABLETS 1 MG(REPAGLINIDE ARRREPAGLINIDE MYLAN PH. 2MGTAB 15'S(6X15'SREPAGLINIDE MYLAN PH 2MG TAB 15'S 6X15'S | $341.2K | 5 | 4.9% |
| 10 | AURO PHARMA INC,CANADA REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $256.4K | 5 | 3.7% |
| 11 | ARROW GENERIQUESFRANCE REPAGLINIDE TABLETS 1 MG(REPAGLINIDE ARRREPAGLINIDE MYLAN PH. 2MGTAB 15'S(6X15'SREPAGLINIDE MYLAN PH 2MG TAB 15'S 6X15'S | $156.2K | 5 | 2.3% |
| 12 | APL SWIFT SERVICES MALTA LTDMALTA REPAGLINIDE TABLETS 0.5 MG 9X10'S (REPAGREPAGLINIDE TABLETS 2 MG 9X10'SREPAGLINIDE TABLETS 0.5 MG9X10'S | $127.3K | 5 | 1.8% |
| 13 | AURO PHARMA INC.,CANADA REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $124.2K | 5 | 1.8% |
| 14 | AURO PHARMA INCCANADA REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $122.8K | 5 | 1.8% |
| 15 | MACLEODS PHARMA USA INCUNITED STATES REPAGLINIDE TABLETS 1 MG 100'SREPAGLINIDE TABLETS 2 MG REPAGLINIDE TABLETS USP 2 MG 100'SREPAGLINIDE TABLETS 2 MG 100'S | $118.1K | 5 | 1.7% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Repaglinide — and from which countries?
Flow of Repaglinide exports from India: each country's share and the named importers behind the numbers
Repaglinide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $4.2M through 116 shipments. This represents a market share of 60.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• AUROLOGISTICS LLC (AUROBINDO PHARMA - $511.2K (12.2% of country's total business)
• AUROLOGISTICS LLC, (AUROBINDO PHARM - $483.3K (11.6% of country's total business)
• RISING PHARMA HOLDINGS INC - $463.1K (11.1% of country's total business)
• AUROLOGISTICS LLC(AUROBINDO PHARMA - $461.1K (11.0% of country's total business)
• RISING PHARMA HOLDINGS, INC. ,. - $452.3K (10.8% of country's total business)
• Rest of United States's importers - $1.8M (43.2% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $36.0K, indicating premium pricing strategy compared to the market average of $8.4K.
United States is a key market for Repaglinide imports, representing 60.4% of total trade value.
2France
France emerges as the second largest importing country, achieving a total trade value of $1.1M through 94 shipments. This represents a market share of 15.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• ARROW GENERIQUES, - $341.2K (31.4% of country's total business)
• ARROW GENERIQUES - $156.2K (14.4% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $11.6K, indicating premium pricing strategy compared to the market average of $8.4K.
France is a key market for Repaglinide imports, representing 15.7% of total trade value.
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $503.4K through 29 shipments. This represents a market share of 7.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• AURO PHARMA INC, - $256.4K (50.9% of country's total business)
• AURO PHARMA INC., - $124.2K (24.7% of country's total business)
• AURO PHARMA INC - $122.8K (24.4% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $17.4K, indicating premium pricing strategy compared to the market average of $8.4K.
Canada is a key market for Repaglinide imports, representing 7.3% of total trade value.
4Vietnam
Vietnam emerges as the fourth largest importing country, achieving a total trade value of $272.7K through 2 shipments. This represents a market share of 3.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• DELTA IMPORT EXPORT MEDICAL CO. LTD - $84.6K (31.0% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $136.4K, indicating premium pricing strategy compared to the market average of $8.4K.
Vietnam is a key market for Repaglinide imports, representing 3.9% of total trade value.
5Croatia
Croatia emerges as the fifth largest importing country, achieving a total trade value of $246.6K through 6 shipments. This represents a market share of 3.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Croatia has a diverse importer base, with their top importers including:
• NOVATIN LIMITED - $96.1K (38.9% of country's total business)
Key Insight: Croatia demonstrates strong market positioning with an average shipment value of $41.1K, indicating premium pricing strategy compared to the market average of $8.4K.
Croatia is a key market for Repaglinide imports, representing 3.6% of total trade value.
Buyer Segment Analysis
TransData Nexus Repaglinide buyer market intelligence
1Buyer Segment Analysis
Repaglinide, an antidiabetic medication, is imported from India by various entities, primarily classified into the following segments:
1. Distributors: These entities purchase large quantities of Repaglinide to supply to pharmacies, hospitals, and other healthcare providers. Their buying behavior is characterized by bulk orders and regular procurement schedules to maintain a steady supply chain. In our data, AUROLOGISTICS LLC (AUROBINDO PHARMA) in the United States, with imports totaling $0.51 million, exemplifies this category.
2. Contract Manufacturers: These companies import Repaglinide as an active pharmaceutical ingredient (API) to produce finished dosage forms. Their procurement patterns depend on production schedules and demand forecasts. RISING PHARMA HOLDINGS INC in the United States, importing $0.46 million worth of Repaglinide, falls into this segment.
3. Re-exporters: Some buyers import Repaglinide with the intent to re-export to other markets, often after repackaging or further processing. Their purchasing behavior is influenced by global market demands and regulatory considerations. ARROW GENERIQUES in France, with imports totaling $0.34 million, is indicative of this segment.
The high repeat buyer rate of 79.5% suggests strong, ongoing relationships between Indian exporters and these buyers, reflecting consistent demand and satisfaction with the product quality and supply reliability.
Country-Specific Import Regulations
TransData Nexus Repaglinide buyer market intelligence
1Country-Specific Import Regulations
Importing Repaglinide into the top five importing countries involves adherence to specific regulatory frameworks:
1. United States:
2. France:
3. Canada:
4. Vietnam:
5. Croatia:
Demand Drivers & Market Opportunity
TransData Nexus Repaglinide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Repaglinide in importing countries is driven by several factors:
1. Disease Prevalence: Type 2 diabetes mellitus (T2DM) is a significant public health concern globally. According to the World Health Organization (WHO), the prevalence of diabetes has been steadily increasing, with an estimated 422 million adults affected worldwide as of 2025. This rising prevalence directly correlates with increased demand for antidiabetic medications like Repaglinide.
2. Government Healthcare Programs: Many countries have implemented national health programs aimed at managing chronic diseases, including diabetes. For instance, Canada's public healthcare system covers prescription medications for eligible populations, facilitating access to essential drugs. Similarly, France's Assurance Maladie provides reimbursement for diabetes treatments, ensuring patient access to necessary medications.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased access to essential medicines. Countries like Vietnam have been expanding their UHC schemes, resulting in greater availability and affordability of medications for chronic conditions.
4. WHO Essential Medicines List Procurement: The inclusion of antidiabetic drugs in the WHO Essential Medicines List encourages countries to prioritize their procurement and distribution. This inclusion supports the availability of medications like Repaglinide in public health systems.
5. Tender-Based Purchasing: Many governments and healthcare institutions utilize tender systems to procure pharmaceuticals, ensuring cost-effective and large-scale acquisition of essential medicines. This approach often leads to stable demand for drugs like Repaglinide, as suppliers compete to fulfill substantial orders.
Our data indicates that 112 buyers across 36 countries have imported Repaglinide from India, reflecting a broad and sustained global demand for this medication.
Common Questions — Repaglinide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest repaglinide buyer importing from India?
Based on import volume and value, AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) leads with $511.2K in imports and a 7.4% market share — the highest of any single repaglinide importer. AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and RISING PHARMA HOLDINGS INC (UNITED STATES) are the next largest buyers.
QHow many companies buy repaglinide from India?
There are 112 active repaglinide buyers importing from India, with a combined market of $6.9M across 819 shipments to 36 countries. The top 5 buyers hold 34.3% of total import value, while the remaining 107 buyers handle the other 65.7%.
QWhich countries import the most repaglinide from India?
The top importing countries for repaglinide from India are United States (60.4%), France (15.7%), Canada (7.3%), Vietnam (3.9%), Croatia (3.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of repaglinide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for repaglinide from India?
The average import transaction value for repaglinide from India is $8.4K, with an average unit price of $1.54 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Repaglinide buyer market intelligence
1Buyer Segment Analysis
Repaglinide, an antidiabetic medication, is imported from India by various entities, primarily classified into the following segments:
1. Distributors: These entities purchase large quantities of Repaglinide to supply to pharmacies, hospitals, and other healthcare providers. Their buying behavior is characterized by bulk orders and regular procurement schedules to maintain a steady supply chain. In our data, AUROLOGISTICS LLC (AUROBINDO PHARMA) in the United States, with imports totaling $0.51 million, exemplifies this category.
2. Contract Manufacturers: These companies import Repaglinide as an active pharmaceutical ingredient (API) to produce finished dosage forms. Their procurement patterns depend on production schedules and demand forecasts. RISING PHARMA HOLDINGS INC in the United States, importing $0.46 million worth of Repaglinide, falls into this segment.
3. Re-exporters: Some buyers import Repaglinide with the intent to re-export to other markets, often after repackaging or further processing. Their purchasing behavior is influenced by global market demands and regulatory considerations. ARROW GENERIQUES in France, with imports totaling $0.34 million, is indicative of this segment.
The high repeat buyer rate of 79.5% suggests strong, ongoing relationships between Indian exporters and these buyers, reflecting consistent demand and satisfaction with the product quality and supply reliability.
Country-Specific Import Regulations
TransData Nexus Repaglinide buyer market intelligence
1Country-Specific Import Regulations
Importing Repaglinide into the top five importing countries involves adherence to specific regulatory frameworks:
1. United States:
2. France:
3. Canada:
4. Vietnam:
5. Croatia:
Demand Drivers & Market Opportunity
TransData Nexus Repaglinide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Repaglinide in importing countries is driven by several factors:
1. Disease Prevalence: Type 2 diabetes mellitus (T2DM) is a significant public health concern globally. According to the World Health Organization (WHO), the prevalence of diabetes has been steadily increasing, with an estimated 422 million adults affected worldwide as of 2025. This rising prevalence directly correlates with increased demand for antidiabetic medications like Repaglinide.
2. Government Healthcare Programs: Many countries have implemented national health programs aimed at managing chronic diseases, including diabetes. For instance, Canada's public healthcare system covers prescription medications for eligible populations, facilitating access to essential drugs. Similarly, France's Assurance Maladie provides reimbursement for diabetes treatments, ensuring patient access to necessary medications.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased access to essential medicines. Countries like Vietnam have been expanding their UHC schemes, resulting in greater availability and affordability of medications for chronic conditions.
4. WHO Essential Medicines List Procurement: The inclusion of antidiabetic drugs in the WHO Essential Medicines List encourages countries to prioritize their procurement and distribution. This inclusion supports the availability of medications like Repaglinide in public health systems.
5. Tender-Based Purchasing: Many governments and healthcare institutions utilize tender systems to procure pharmaceuticals, ensuring cost-effective and large-scale acquisition of essential medicines. This approach often leads to stable demand for drugs like Repaglinide, as suppliers compete to fulfill substantial orders.
Our data indicates that 112 buyers across 36 countries have imported Repaglinide from India, reflecting a broad and sustained global demand for this medication.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 112 global importers of Repaglinide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 819 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 36 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
819 Verified Shipments
112 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists